Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India
This study has been completed.
Study NCT00074841 Information provided by Pfizer
First Received: December 22, 2003 Last Updated: January 30, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plasmodium Falciparum Malaria
Additional conditions recognized in this trial
Malaria
Malaria, Falciparum
More general conditions related to this trial
Coccidiosis
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Azithromycin/Chloroquine
Additional drug interventions recognized in this trial
Azithromycin
Chloroquine
Chloroquine diphosphate
Pyrimethamine
Sulfadoxine
Sulfadoxine-pyrimethamine
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Enzyme Inhibitors
Filaricides
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer
Back to top of Main Content
